Pristiq approved for MDD

Pristiq approved for MDD
Pristiq approved for MDD

Wyeth has received FDA approval for Pristiq (desvenlafaxine) for the treatment of adult patients with major depressive disorder (MDD).Pristiq, a once-daily serotonin-norepinephrine reuptake inhibitor (SNRI), is expected to be available in May 2008.

For more information call (800) 934-5556 or visit www.pristiq.com.